Publication: 738

Publication: 738

A phase II study of the VEGFR inhibitor pazopanib (P) in patients with newly diagnosed or relapsed malignant pleural mesothelioma (MPM): an NCCTG study

URL

Google Scholar

Citation:: J Thorac Oncol vol 4 (9 suppl 1) PD4.1.2, S456

Meeting Instance:: IASLC (WCLC) 2009
Year:: 2009
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 2221

Program:: OGC
Primary Committee:: Respiratory
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: J. R. Molina S. J. Mandrekar K. L. Allen Ziegler G. S. Soori K. M. Rowland Jr S. E. Schild P. Ivy A. A. Adjei

Networks:

Study: NCCTG-N0623
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: